The Duchenne Family Support Group

	Page
Reference and Administrative Details	1
Trustees' Report	2—3
Independent Examiner's Report	4
Statement of Financial Activities (including Income and Expenditure Account)	5
Comparative Statement of Financial Activities (including Income and Expenditure Account)	6
Balance Sheet	7
Notes to the Financial Statements	8—12

The trustees present their report and the financial statements for the year ended 31 March 2026.

Objectives and Activities

Aims and Objectives

The objectives of the charitable company are:

To provide a positive national support network of families affected by Duchenne Muscular Dystrophy.

To enable families to come together to share ideas and experiences and to enjoy social events.

Raising funds is always high on our priority list and the year saw us undertake sponsored events including the London Marathon. We also receive significant support from our member families.

Services were maintained in the following areas:

Helpline: We operate a helpline to receive calls from families and professionals. Our Vice-Chair dealt with the queries herself or passed them on to an appropriate person or organisation.

News and information: The charity publishes a regular newsletter containing articles, many from our family members, sharing experienses and ideas. Feedback is also provided on research progress and other matters impacting on families of disabled children and adults. We also have a website, and a Facebook page - all of which we use in addition to our newsletter to keep families up to date with news and events.

Events: The charity continues providing social events and holidays where families can enjoy a relaxed atmosphere whilst sharing their experiences and ideas.

Public Benefit

In setting out our objectives and planning our activities, the trustees have given careful consideration to the Charity Commission’s general guidance on public benefit.

The trustees confirm that they have complied with the requirements of Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s guidance on public benefit.

Future Plans

We continually strive to expand our services to meet the growing demand but we do so in a planned and financially prudent way, thus ensuring all projects stand on a sound financial footing individually and thus the charity moves forward and grows but does so responsibly.

Financial Review

Financial Position

Each service we offer is carefully budgeted for and only runs after being sanctioned by the trustees as viable. The excess of expenditure over income in the year amounted to £5,427 (2025 surplus of £6,788). Reserves at 31 March 2026 were £62,030.

Reserves Policy

Investment powers and policy

Under the Memorandum and Articles of Association, the charitable company has the power to make any investment which the trustees see fit.

Reserves policy

Our policy is to have a minimum of 3 months’ running costs as a reserve figure. At present the free reserves, which amount to £62,030 are above this target level.

Page 2

Page 3

The Duchenne Family Support Group

Trustees' Report (continued)

For The Year Ended 31 March 2026

Structure, Governance and Management

Governing Document

The Duchenne Family Support Group is a registered charity (charity number 1128653) and a company limited by guarantee (company number 06134522). The company was formed on 2 March 2007 and achieved registered charity status on 18 March 2009.

The charitable company is governed by its Memorandum and Articles of Association.

Trustee Selection Methods

Appointment of trustees

Trustees are appointed by the Members at the Annual General Meeting in accordance with the charitable company’s Memorandum and Articles of Association. No external bodies have the right to appoint trustees.

Trustee induction and training

New trustee directors are introduced to the operations of the organisation and are given information on the responsibilities of being a trustee and director as well as copies of the charitable company’s Memorandum and Articles of Association. Training is provided to trustee directors when required.

Organisation

The board of trustees, or the Executive Committee, of between 3 and 15 members who meet regularly, administer the charitable company.

Statement of Trustees' Responsibilities

The trustees (who are also the directors of The Duchenne Family Support Group for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year. Under company law the trustees must not approve the financial statement unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing the financial statements the trustees are required to:

select suitable accounting policies and then apply them consistently;
observe the methods and principles in the Charity SORP;
make judgments and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The trustees are responsible for keeping adequate accounting records which disclose with reasonable accuracy at anytime the financial position of the charitable company and to enable them to ensure that the accounts comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Small Company Rules

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The trustees' report was approved by the board of trustees and signed on its behalf by:

Dr S Meech

Trustee

28/09/2026

Page 3

Page 4

The Duchenne Family Support Group

Independent Examiner's Report to the Trustees of The Duchenne Family Support Group

For The Year Ended 31 March 2026

Independent Examiner's Report to the Trustees of The Duchenne Family Support Group

I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 March 2026.

Responsibilities and Basis of Report

As the charity trustees of the Company (and also its directors for the purposes of company law), you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (“the 2006 Act”).

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity’s accounts as carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.

Independent Examiner's Statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or
the accounts do not accord with those records; or
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair view' which is not a matter considered as part of an independent examination; or
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Marcus Cridland B.A.(Hons)F.C.A.

14/10/2026

65 East Street
Bridport
Dorset
DT6 3LB

Page 4

Page 5

The Duchenne Family Support Group

Statement of Financial Activities (including Income and Expenditure Account)

For The Year Ended 31 March 2026

Statement of Financial Activities (including Income and Expenditure Account)

		2026	2025
		Unrestricted funds	Total funds
	Notes	£	£
INCOME AND ENDOWMENTS FROM:
Donations and legacies	3	16,360	10,153
Charitable activities:
Relieve persons suffering from Duchenne Muscular Dystrophy		36,807	40,971
Investments	4	301	-

		53,468	51,124

EXPENDITURE ON:
Raising funds	5	(2,124 )	(2,436 )
Charitable activities:	5
Relieve persons suffering from Duchenne Muscular Dystrophy		(56,771 )	(41,900 )

		(58,895 )	(44,336 )

NET (EXPENDITURE)/INCOME		(5,427 )	6,788


NET MOVEMENT IN FUNDS		(5,427 )	6,788
RECONCILIATION OF FUNDS:
Total funds brought forward		67,457	60,669

TOTAL FUNDS CARRIED FORWARD	13	62,030	67,457

The notes on pages 8 to 12 form part of these financial statements.

Page 5

Page 6

The Duchenne Family Support Group

Comparative Statement of Financial Activities (including Income and Expenditure Account)

For The Year Ended 31 March 2026

Comparative Statement of Financial Activities (including Income and Expenditure Account)

				2025
		Unrestricted funds	Restricted funds	Total funds
	Notes	£	£	£
INCOME AND ENDOWMENTS FROM:
Donations and legacies	3	9,403	750	10,153
Charitable activities:
Relieve persons suffering from Duchenne Muscular Dystrophy		27,552	13,419	40,971

		36,955	14,169	51,124

EXPENDITURE ON:
Raising funds	5	(2,436 )	-	(2,436 )
Charitable activities:	5
Relieve persons suffering from Duchenne Muscular Dystrophy		(14,489 )	(27,411 )	(41,900 )

		(16,925 )	(27,411 )	(44,336 )

NET INCOME		20,030	(13,242 )	6,788

Transfers between funds	13	(1,787 )	1,787	-

NET MOVEMENT IN FUNDS		18,243	(11,455 )	6,788
RECONCILIATION OF FUNDS:
Total funds brought forward		49,214	11,455	60,669

TOTAL FUNDS CARRIED FORWARD	13	67,457	-	67,457

The notes on pages 8 to 12 form part of these financial statements.

Page 6

Page 7

The Duchenne Family Support Group

Balance Sheet

As At 31 March 2026

Balance Sheet

				2026	2025
		Unrestricted funds	Restricted funds	Total funds	Total funds
	Notes	£	£	£	£
CURRENT ASSETS
Debtors	10	8,748	-	8,748	11,357
Cash at bank and in hand		62,372	-	62,372	61,817

		71,120	-	71,120	73,174
Creditors: Amounts Falling Due Within One Year	11	(9,090 )	-	(9,090 )	(5,717 )

NET CURRENT ASSETS (LIABILITIES)		62,030	-	62,030	67,457

TOTAL ASSETS LESS CURRENT LIABILITIES		62,030	-	62,030	67,457

NET ASSETS		62,030	-	62,030	67,457

FUNDS OF THE CHARITY
Unrestricted Funds				62,030	67,457

TOTAL FUNDS	13			62,030	67,457

For the year ending 31 March 2026 the charitable company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

On behalf of the board

Dr S Meech

Trustee

28/10/2026

The notes on pages 8 to 12 form part of these financial statements.

Page 7

Page 8

The Duchenne Family Support Group

Notes to the Financial Statements

For The Year Ended 31 March 2026

Notes to the Financial Statements

1. General Information

The Duchenne Family Support Group is a company limited by guarantee, incorporated in England & Wales, registered number 06134522 and registered charity number 1128653 . The registered office is 78 York Street, London, W1H 1DP.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)", Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

The charitable company is a Public Benefit Entity as defined by FRS 102.

2.2. Going Concern Disclosure

The trustees have not identified any material uncertainties related to events or conditions that may cast significant doubt about the charitable company's ability to continue as a going concern.

2.3. Fund Accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Designated funds comprise unrestricted funds that have been set aside by the trustees for a specific purpose.

Restricted funds are to be used for specific purposes as laid down by the donor.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

2.4. Incoming Resources

Voluntary income including donations, gifts and legacies and grants that provide core funding or are of a general nature are recognised where there is entitlement, certainty of receipt and the amount can be quantified with reasonable accuracy. Such income is only deferred when:

The donor specifies that the grant or donation must only be used in future accounting periods; or

The donor has imposed conditions which must be met before the charity has unconditional entitlement.

Investment income is recognised on a receivable basis.

2.5. Donated Goods and Services

The value of services provided by volunteers is not incorporated into these financial statements. Further details of the contribution made by volunteers can be found in the trustees’ annual report.

2.6. Resources Expended

Expenditure is recognised when a liability is incurred.

Costs of raising funds are those costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

Charitable activities include expenditure associated with the production of the newsletter and other information, provision of a helpline and volunteer network services and provision of events and holidays, together with support costs relating to these activities.

Governance costs include those incurred in the governance of the charity and its assets and are primarily associated with constitutional and statutory requirements.

Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources.

Page 8

Page 9

The Duchenne Family Support Group

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

2.7. Cash and Cash Equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks, other short-term highly liquid investments that mature in no more than three months from the date of acquisition and are readily convertible to a known amount of cash with insignificant risk of change in value, and bank overdrafts.

2.8. Financial Instruments

Classification

Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangement entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities.

Recognition and measurement

All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transactions. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for similar debt instruments.

Financial assets and liabilities are only offset in the statement of financial position when, and only when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Financial assets are derecognised when and only when a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or c) the charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires.

3. Income from Donations and Legacies

			2026
	Unrestricted	Restricted	Total
	funds	funds	funds
	£	£	£
Donations and gifts	15,852	-	15,852
Gift aid	508	-	508
Grants	-	-	-

	16,360	-	16,360

			2025
	Unrestricted	Restricted	Total
	funds	funds	funds
	£	£	£
Donations and gifts	7,339	-	7,339
Gift aid	2,064	-	2,064
Grants	-	750	750

	9,403	750	10,153

Page 9

Page 10

The Duchenne Family Support Group

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

4. Investment Income

	2026	2025
	Unrestricted	Unrestricted
	funds	funds
	£	£
Interest on short-term deposits	301	-

5. Analysis of Expenditure

			2026
	Activities undertaken directly	Support costs (see note 6 )	Total
	£	£	£
Raising funds	2,124	-	2,124
Relieve persons suffering from Duchenne Muscular Dystrophy	51,284	5,487	56,771

	53,408	5,487	58,895

			2025
	Activities undertaken directly	Support costs (see note 6 )	Total
	£	£	£
Raising funds	2,436	-	2,436
Relieve persons suffering from Duchenne Muscular Dystrophy	36,541	5,359	41,900

	38,977	5,359	44,336

6. Support Costs

	2026	2025
	Relieve persons suffering from Duchenne Muscular Dystrophy	Relieve persons suffering from Duchenne Muscular Dystrophy
	£	£
Employee costs:
Wages and salaries	2,173	1,274
General administration:
Insurance	684	659
Postage, stationery and office costs	-	985
Postage	1,072	-
Telecommunications and data costs	6	5
Accountancy fees	424	528

...CONTINUED

Page 10

Page 11

The Duchenne Family Support Group

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

Subscriptions	-	756
Governance costs:
Independent examiner's fees	1,128	1,152

	5,487	5,359

7. Independent Examiner's Remuneration

	2026	2025
	£	£
Independent examination of the financial statements	1,128	1,152

8. Staff Costs

Staff costs were as follows:

	2026	2025
	£	£
Wages and salaries	2,173	1,274

No employees received employee benefits (excluding employer pension costs) for the reporting period of more than £60,000.

9. Average Number of Employees

Average number of employees during the year was: 1 (2025: 1)

10. Debtors

	2026	2025
	£	£
Due within one year
Other debtors	8,748	11,357

11. Creditors: Amounts Falling Due Within One Year

	2026	2025
	£	£
Accruals and deferred income	9,090	5,717

12. Financial Instruments

The charitable company has the following financial instruments:

	2026	2025
	£	£
Financial assets
Financial assets that are debt Instruments measured at amortised cost	62,372	61,817

Financial liabilities
Financial liabilities measured at amortised cost	9,090	5,717

Items of income, expense, gains or losses

The total interest income for financial assets not measured at fair value through profit or loss is £301 (2025: £nil).

Page 11

Page 12

The Duchenne Family Support Group

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

13. Movement in Funds

	As at 1 April 2025	Income	Expenditure	As at 31 March 2026
	£	£	£	£
Unrestricted funds
General:
General unrestricted fund	67,457	53,468	(58,895 )	62,030


Total funds	67,457	53,468	(58,895 )	62,030

	As at 1 April 2024	Income	Expenditure	Transfers	As at 31 March 2025
	£	£	£	£	£
Unrestricted funds
General:
General unrestricted fund	49,214	36,955	(16,925 )	(1,787 )	67,457
Restricted funds
Pears fund	4,205	-	-	(4,205)	-
Events fund	7,250	14,169	(27,411)	5,992	-


Total restricted funds	11,455	14,169	(27,411 )	1,787	-




Total funds	60,669	51,124	(44,336 )	-	67,457

14. Transactions with Trustees

None of the trustees received any remuneration or any other benefits from an employment with the charity or a related entity during the current or previous year.

No trustee expenses have been incurred.

15. Related Party Disclosures

Donations totalling £550 were made to the charity by five trustees during the year.

16. Company limited by guarantee

The company is limited by guarantee and has no share capital.

Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.

Page 12

Trustees	Dr S Meech - Chair
	Mrs S Berry
	Mrs L Elliott
	Ms K Lightly
	Ms C Parker
	Mrs A Revell
	Mrs S Wright


Charity Number	1128653

Company Number	06134522

Registered Office	78 York Street
	London
	W1H 1DP

Independent Examiner	Marcus Cridland B.A.(Hons)F.C.A.
	Scott Vevers Ltd
	Chartered Accountants & Registered Auditors
	65 East Street Bridport Dorset DT6 3LB

Bankers	Barclays Bank plc
	90 Osborne Road
	Southsea
	Hants
	PO5 3LW